Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 33.21B | 4.46%42.74B | 4.12%138.46B | 1.18%31.59B | 10.69%40.92B | 7.83%132.99B | 8.29%36.13B | 9.40%28.67B | 9.90%31.23B | 4.58%36.97B |
| Cost of revenue | 19.67B | -2.25%23.99B | 3.11%83.26B | 4.92%19.89B | 10.48%24.55B | 4.09%80.74B | 3.30%22.09B | 4.82%17.48B | 5.13%18.96B | 3.42%22.22B |
| Gross profit | 13.54B | 14.52%18.75B | 5.67%55.2B | -4.61%11.71B | 11.01%16.37B | 14.19%52.24B | 17.18%14.04B | 17.39%11.18B | 18.21%12.27B | 6.39%14.75B |
| Operating expense | 12.56B | 9.63%11.33B | 3.22%45.12B | 8.27%10.88B | 3.64%10.33B | 6.19%43.72B | 10.54%12.69B | 12.17%11.01B | 0.74%10.05B | 0.73%9.97B |
| Operating profit | 988M | 22.90%7.42B | 18.23%10.08B | -62.81%827M | 26.39%6.04B | 86.01%8.52B | 171.31%1.34B | 162.46%178M | 445.10%2.22B | 20.53%4.78B |
| Net non-operating interest income (expenses) | -157M | -108.16%-102M | -113.53%-284M | -125.71%-79M | -32.43%-49M | 5.67%-133M | 18.92%-30M | 8.82%-31M | 18.60%-35M | -37.04%-37M |
| Non-operating interest income | --9M | 300.00%8M | 22.22%22M | 16.67%7M | 100.00%2M | 80.00%18M | 66.67%5M | 200.00%6M | 220.00%6M | -90.00%1M |
| Non-operating interest expense | --166M | 115.69%110M | 102.65%306M | 109.76%86M | 34.21%51M | 0.00%151M | -12.50%35M | 2.78%37M | 7.89%41M | 2.70%38M |
| Net investment income | 24M | 400.00%65M | 15.71%243M | 11.36%49M | -40.91%13M | 165.82%210M | 850.00%38M | 26.19%106M | 241.94%44M | 0.00%22M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 135M | 14M | -84.48%27M | 100.00%26M | 0 | 64.15%174M | 47M | 8.65%113M | 550.00%13M | 1M |
| Income from associates and other participating interests | 0 | 0 | 0 | -166.67%-16M | -466.67%-17M | -3M | 300.00%2M | 200.00%2M | ||
| Special income (charges) | 166M | -733.33%-75M | 145.95%142M | 18,800.00%567M | 55.00%-9M | -107.83%-309M | -108.34%-263M | -20.83%-29M | -95.83%3M | -102.69%-20M |
| Less:Other special charges | ---166M | 733.33%75M | -145.95%-142M | -18,800.00%-567M | -55.00%9M | 105.39%309M | 105.33%263M | 52.63%29M | 95.83%-3M | 102.69%20M |
| Less:Write off | ---- | ---- | --0 | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -24M | -709.09%-67M | -90.00%-133M | -350.00%-60M | -81.03%11M | 63.54%-70M | 31.94%-179M | 148.21%27M | -78.18%24M | 241.18%58M |
| Income before tax | 1.13B | 20.83%7.26B | 20.21%10.07B | -41.63%1.33B | 25.02%6.01B | 0.07%8.38B | -72.07%936M | 272.04%363M | 340.89%2.28B | 1.87%4.8B |
| Income tax | 421M | 23.41%2.35B | 15.26%2.85B | -60.23%344M | 26.23%1.9B | -22.56%2.47B | -103.79%-60M | 861.90%160M | 250.20%865M | 9.05%1.51B |
| Net income | 711M | 19.64%4.91B | 22.28%7.22B | -30.19%985M | 24.48%4.1B | 14.01%5.91B | -43.58%997M | 206.32%202M | 424.54%1.41B | -1.14%3.3B |
| Net income continuous operations | --711M | 19.63%4.91B | 22.28%7.22B | -30.21%984M | 24.47%4.11B | 14.01%5.91B | -43.63%996M | 206.84%203M | 424.16%1.41B | -1.11%3.3B |
| Noncontrolling interests | 10M | -400.00%-6M | 3,800.00%39M | 1M | 100.00%2M | 100.88%1M | 0 | 0 | 0 | 101.89%1M |
| Net income attributable to the company | 699M | 19.87%4.92B | 21.64%7.18B | -30.19%985M | 24.42%4.1B | 11.54%5.91B | -43.95%996M | 227.04%202M | 389.93%1.41B | -2.72%3.3B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 699M | 19.87%4.92B | 21.64%7.18B | -30.19%985M | 24.42%4.1B | 11.54%5.91B | -43.95%996M | 227.04%202M | 389.93%1.41B | -2.72%3.3B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 14.06 | 16.57%99.9103 | 12.84%147.02 | -38.46%19.14 | 17.73%85.71 | 11.37%130.29 | -44.04%21.97 | 224.86%4.42 | 392.09%31.1 | -2.87%72.8 |
| Diluted earnings per share | 14.06 | 16.57%99.9103 | 32.12%147.02 | -18.66%19.14 | 26.60%85.71 | -2.42%111.28 | -51.54%17.94 | 159.60%2.11 | 272.31%23.53 | -9.67%67.7 |
| Dividend per share | 0 | 0 | 30.95%55 | 0 | 0 | 147.06%42 | 147.06%42 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |